Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study.

J Neurol. 2011 Jul 22. [Epub ahead of print]

Meier T, Perlman SL, Rummey C, Coppard NJ, Lynch DR.
Santhera Pharmaceuticals, Liestal, Switzerland.

Keywords: idebenone, neurological function, ICARS, FARS, neurological rating scales, Friedreich's ataxia (FRDA), open-label extension study (IONIA-E), may offer a therapeutic benefit to pediatric FRDA patients.